TMO fell 1.59% as the S&P 500 dropped 1.50%, the Nasdaq fell 2.51%, and the VIX jumped 15.17% on October 30, 2026. The stock had no company news behind it, while life-science peers were mixed and TMO's normal trading volume was only modestly elevated. Recent analyst target increases and third-quarter results were older than the move and did not provide a new trigger.
TMO fell 1.59% as the S&P 500 dropped 1.50%, the Nasdaq fell 2.51%, and the VIX jumped 15.17% on October 30, 2026. The stock had no company news behind it, while life-science peers were mixed and TMO's normal trading volume was only modestly elevated. Recent analyst target increases and third-quarter results were older than the move and did not provide a new trigger.